PRESS RELEASE published on 01/03/2023 at 14:33, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
PRESS RELEASE published on 01/03/2023 at 14:32, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Devro plc
PRESS RELEASE published on 01/03/2023 at 14:30, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
PRESS RELEASE published on 01/03/2023 at 14:27, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Biffa plc
PRESS RELEASE published on 01/03/2023 at 14:25, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
PRESS RELEASE published on 01/03/2023 at 14:23, 1 year 8 months ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 01/03/2023 at 14:15, 1 year 8 months ago X1 Entertainment Group Announces Update on Recent Commercial Progress
PRESS RELEASE published on 01/03/2023 at 14:00, 1 year 8 months ago Accelovant Receives Prestigious Jobs and Growth Fund Support to Expand Manufacturing and R&D in Canada
PRESS RELEASE published on 01/03/2023 at 14:00, 1 year 8 months ago Halberd Corporation 2022 Year End CEO Letter and 2023 Goals
PRESS RELEASE published on 01/03/2023 at 14:00, 1 year 8 months ago Business Update on Spetz US Launch
Published on 09/30/2024 at 13:00, 43 minutes ago Kaas Wilson Architects Expands Into Southwestern U.S. With Office in Phoenix, Arizona
Published on 09/30/2024 at 13:00, 43 minutes ago Coaching.com Announces Leadership Transition: Alex Pascal Moves to Executive Chairman, Charlotte Saulny Appointed CEO.
Published on 09/30/2024 at 13:00, 43 minutes ago Electrovaya and Innovative Rail Technologies Enter into Strategic Supply Agreement for the Supply of Battery Systems for Electric Rail Applications
Published on 09/30/2024 at 13:00, 43 minutes ago Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company
Published on 09/30/2024 at 13:00, 43 minutes ago Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
Published on 09/30/2024 at 13:30, 13 minutes ago ZenaTech Announces Approval to List Common Shares on the Nasdaq Capital Market
Published on 09/30/2024 at 12:48, 55 minutes ago EQS-Adhoc: Blue Cap AG sells subsidiary nokra to Vishal Precision Group
Published on 09/30/2024 at 12:05, 1 hour 37 minutes ago Statement of transactions in own shares from September 23, 2024 to September 27, 2024
Published on 09/30/2024 at 12:04, 1 hour 38 minutes ago Déclaration des transactions sur actions propres réalisées du 23/09/2024 au 27/09/2024
Published on 09/30/2024 at 10:03, 3 hours 40 minutes ago GUILLEMOT CORPORATION: Weekly report share buyback From September 23rd 2024 to September 27th 2024
Published on 09/30/2024 at 10:03, 3 hours 40 minutes ago GUILLEMOT CORPORATION : Déclaration hebdomadaire des transactions sur actions propres Du 23 septembre 2024 au 27 septembre 2024